Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
AAbbott Laboratories logo
ABTNYSE

Abbott Laboratories

Abbott Laboratories
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Jul 16
Earnings 16:00
Q2 earnings
Add to Google Calendar
Jul 15
Ex-dividend Time TBD
Ex-dividend date
Add to Google Calendar
Apr 16
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Jan 22
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2025
Oct 15
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Jul 17
Earnings Time TBD
Q2 earnings
Add to Google Calendar
Apr 16
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Jan 22
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2024
Oct 16
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Oct 14
Est.
Earnings 7:35 approx.
Q3 earnings (predicted)
Add to Google Calendar
Oct 15
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $0.63
Add to Google Calendar
2027
Jan 14
Est.
Earnings 7:35 approx.
FY earnings (predicted)
Add to Google Calendar
Jan 15
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $0.63
Add to Google Calendar
Apr 27
Est.
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar

KPI highlights

FY25
Revenue $44.33B YoY +5.7%
Operating income $8.05B margin 18.2%
Net income $6.52B YoY -51.3%
EPS $3.73 YoY -51.4%
P/E 25.1× Slightly rich Rough PER guide (a simplified band — fair value varies by industry and growth stage): <10 Cheap / 10–15 Slightly cheap / 15–22 Fair / 22–35 Slightly rich / ≥35 Rich
ROE 12.5% Equity ratio 60% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 10,97410,35811,14211,36911,45911,164
Operating income 1,9111,6932,0522,0572,2511,345
Net income 9,2291,3251,7791,6441,7761,077
Operating CF 10,2241,4172,0472,7873,1371,315

Company news

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)(2013–2026)

機関投資家 73.7%未開示 26.3%20132015201720192021202320252026
機関投資家 73.7%未開示 26.3%13Q114Q215Q316Q418Q119Q220Q321Q423Q124Q225Q426Q1
機関投資家その他未開示・浮動株

「国内機関」は信託銀行の名義口座(年金・パッシブ・一部海外資本を含む)を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

BlackRock, Inc. 8.2%BlackRock, Inc.VANGUARD CAPITAL M 6.4%VANGUARD CAPITAL MANAGEMENT LLCSTATE STREET CORP 4.5%STATE STREET CORPCapital Research G 2.8%Capital Research Global InvestorsVANGUARD PORTFOLIO 2.7%VANGUARD PORTFOLIO MANAGEMENT LLCCHARLES SCHWAB INV 2.6%CHARLES SCHWAB INVESTMENT MANAGEMENT INCGEODE CAPITAL MANA 2.2%GEODE CAPITAL MANAGEMENT, LLCCapital Internatio 2.1%Capital International InvestorsMORGAN STANLEY 1.7%MORGAN STANLEYWELLINGTON MANAGEM 1.5%WELLINGTON MANAGEMENT GROUP LLP20132015201720192021202320252026
BlackRock, Inc. 8.2%BlackRock, Inc.VANGUARD CAPITAL M 6.4%VANGUARD CAPITAL MANAGEMENT LLCSTATE STREET CORP 4.5%STATE STREET CORPCapital Research G 2.8%Capital Research Global InvestorsVANGUARD PORTFOLIO 2.7%VANGUARD PORTFOLIO MANAGEMENT LLCCHARLES SCHWAB INV 2.6%CHARLES SCHWAB INVESTMENT MANAGEMENT INCGEODE CAPITAL MANA 2.2%GEODE CAPITAL MANAGEMENT, LLCCapital Internatio 2.1%Capital International InvestorsMORGAN STANLEY 1.7%MORGAN STANLEYWELLINGTON MANAGEM 1.5%WELLINGTON MANAGEMENT GROUP LLP13Q114Q215Q316Q418Q119Q220Q321Q423Q124Q225Q426Q1

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
その他機関投資家(13F 2692社) 465,018,595 26.2% 13F
BlackRock, Inc. 145,687,458 8.2% 13F
VANGUARD CAPITAL MANAGEMENT LLC 112,949,933 6.4% 13F
STATE STREET CORP 79,575,468 4.5% 13F
Capital Research Global Investors 49,775,362 2.8% 13F
VANGUARD PORTFOLIO MANAGEMENT LLC 47,944,891 2.7% 13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 45,500,055 2.6% 13F
GEODE CAPITAL MANAGEMENT, LLC 39,148,795 2.2% 13F
Capital International Investors 37,498,227 2.1% 13F
MORGAN STANLEY 30,101,596 1.7% 13F
WELLINGTON MANAGEMENT GROUP LLP 27,070,518 1.5% 13F
FRANKLIN RESOURCES INC 20,022,905 1.1% 13F
NORTHERN TRUST CORP 19,394,974 1.1% 13F
BANK OF AMERICA CORP /DE/ 19,279,608 1.1% 13F
PRICE T ROWE ASSOCIATES INC /MD/ 17,277,212 1.0% 13F
WELLS FARGO & COMPANY/MN 15,909,341 0.9% 13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 15,499,870 0.9% 13F
GOLDMAN SACHS GROUP INC 14,505,201 0.8% 13F
AMERIPRISE FINANCIAL INC 14,119,549 0.8% 13F
DEUTSCHE BANK AG\ 14,091,704 0.8% 13F
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 13,587,118 0.8% 13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 13,198,740 0.7% 13F
Bank of New York Mellon Corp 12,442,717 0.7% 13F
Legal & General Group Plc 12,285,529 0.7% 13F
UBS Group AG 12,152,765 0.7% 13F
Nuveen, LLC 11,191,853 0.6% 13F

Source:SEC EDGAR(DEF 14A・13D/G・13F) Classification inferred from disclosed names

F-Score (Piotroski)

4/9 1 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

Positive ROA ROA 7.5%
Positive operating cash flow $9.57B
ROA improved YoY 16.5% → 7.5%
Operating CF exceeds net income (accrual quality) OCF $9.57B / net income $6.52B
Equity ratio improved* Substitute for the original “decrease in long-term debt” 58.5% → 60.1%
Current ratio improved 1.67× → 1.58×
No dilution (shares outstanding did not increase) 1,734,323,411 → 1,737,682,887
Gross margin improved No data
Asset turnover improved 0.52× → 0.51×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 60.1%
Current ratio 1.6×
Years of positive operating CF 12 of last 12 yrs
Payout ratio 67%
Latest fiscal year result Profit (net income $6.52B)

Performance history

Last 10 years
$0.0B$11.1B$22.2B$33.2B$44.3B FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 20,85327,39030,57831,90434,60843,07543,65340,10941,95044,328
Operating income 3,0261,5643,6504,5325,3578,4258,3626,4786,8258,053
Ordinary income
Net income 1,4004772,3683,6874,4957,0716,9335,72313,4026,524
Total assets 52,66676,25067,17367,88772,54875,19674,43873,21481,41486,713
Equity 20,53830,89730,52431,08832,78435,80236,68638,60347,66452,130

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

*Split-adjustedUnit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS $0.94$0.27$1.34$2.07$2.52$3.97$3.94$3.28$7.67$3.73
ROE 6.8%1.5%7.8%11.9%13.7%19.8%18.9%14.8%28.1%12.5%
Operating CF 3,2035,5706,3006,1367,90110,5339,5817,2618,5589,566
Investing CF -248-9,618-1,356-1,815-2,215-2,008-1,740-3,133-2,338-2,422
Financing CF 11,147-5,281-10,391-4,289-2,779-5,494-7,636-7,091-5,404-6,309
FCF 5,7248,6487,8045,0596,3517,395

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-05) *Some metrics supplemented from additional sources

Key financial metrics

Dividend grower

Sector positioning

Relative standing within the sector

Data provided by Twelve Data